India’s drug regulator has barred pharmaceutical companies from promoting weight-loss drugs, warning against direct and surrogate advertising.
Agilent signs $950 million deal to acquire Biocare Medical, enhancing its cancer diagnostics and pathology portfolio with innovative IHC and molecular pathology solutions.
Abbott introduces XIENCE Skypoint in India, an advanced stent for treating complex heart blockages. It offers greater flexibility, precision, and improved treatment options for patients.
Mankind Pharma and health experts emphasize early screening for chronic kidney disease (CKD) on World Kidney Day, urging proactive kidney health and regular check-ups to prevent progression.
The Ministry of Health and Family Welfare (MoHFW) has published a draft Gazette notification proposing an amendment to the Drugs Rules, 1945, to make changes to the requirements of testing of blood products.
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has urged Indian pharmaceutical exporters to diversify shipping routes and explore alternative logistics options as tensions in the Gulf region threaten key global trade corrid...
AbbVie reported encouraging Phase 1 results for its experimental obesity therapy ABBV-295, showing meaningful weight loss and a favorable safety profile in adults during a 12–13 week clinical study.
Bristol Myers Squibb reported positive results from a late-stage trial of its experimental drug mezigdomide for multiple myeloma, showing improved progression-free survival in patients whose cancer returned or resisted prior treatment.
Neuland Laboratories is expanding into commercial peptide manufacturing with a new facility at its Bonthapally campus near Hyderabad. The first module, expected by summer 2026, already has USD 30 million in customer commitments.
Alcon launches Hydrus Microstent in India for minimally invasive glaucoma management. This device lowers intraocular pressure with proven clinical outcomes and rapid recovery.